APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Oral Anti-Diabetic Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Oral Anti-Diabetic Drug Market Analysis and Forecast 2026-2032

Report ID 17401952022 January 2026192 pages

Choose your research edition.

Industry ResearchOral Anti-Diabetic Drug Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Anti-Diabetic Drug Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Oral Anti-Diabetic Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Anti-Diabetic Drug Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Anti-Diabetic Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Oral Anti-Diabetic Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Oral Anti-Diabetic Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Oral Anti-Diabetic Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Oral Anti-Diabetic Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Oral Anti-Diabetic Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Oral Anti-Diabetic Drug include Astellas, Biocon, Boehringer Ingelheim, Bristol Myers Squibb, Merck And Co., AstraZeneca, Pfizer, Eli Lilly and Novartis, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Oral Anti-Diabetic Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Oral Anti-Diabetic Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Oral Anti-Diabetic Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oral Anti-Diabetic Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Oral Anti-Diabetic Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Oral Anti-Diabetic Drug sales, projected growth trends, production technology, application and end-user industry.

Oral Anti-Diabetic Drug Segment by Company

Astellas

Biocon

Boehringer Ingelheim

Bristol Myers Squibb

Merck And Co.

AstraZeneca

Pfizer

Eli Lilly

Novartis

Sanofi

Takeda

Abbott

Janssen Pharmaceuticals

Oral Anti-Diabetic Drug Segment by Type

Gliclazide

Glimepiride

Glyburide

Others

Oral Anti-Diabetic Drug Segment by Application

Hospital

Research Institual

Oral Anti-Diabetic Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Anti-Diabetic Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Anti-Diabetic Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Anti-Diabetic Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Oral Anti-Diabetic Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Oral Anti-Diabetic Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Anti-Diabetic Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Oral Anti-Diabetic Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Gliclazide Major Manufacturers Table 3. Glimepiride Major Manufacturers Table 4. Glyburide Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Oral Anti-Diabetic Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Manufacturers Table 8. Research Institual Major Manufacturers Table 9. Oral Anti-Diabetic Drug Industry Trends Table 10. Oral Anti-Diabetic Drug Industry Drivers Table 11. Oral Anti-Diabetic Drug Industry Opportunities and Challenges Table 12. Oral Anti-Diabetic Drug Industry Restraints Table 13. Global Oral Anti-Diabetic Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Oral Anti-Diabetic Drug Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Oral Anti-Diabetic Drug Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Oral Anti-Diabetic Drug Revenue Market Share by Region (2021-2026) Table 17. Global Oral Anti-Diabetic Drug Revenue Market Share by Region (2027-2032) Table 18. Global Oral Anti-Diabetic Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 19. Global Oral Anti-Diabetic Drug Sales by Region (2021-2026) & (Tons) Table 20. Global Oral Anti-Diabetic Drug Sales by Region (2027-2032) & (Tons) Table 21. Global Oral Anti-Diabetic Drug Sales Market Share by Region (2021-2026) Table 22. Global Oral Anti-Diabetic Drug Sales Market Share by Region (2027-2032) Table 23. Global Oral Anti-Diabetic Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Oral Anti-Diabetic Drug Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Oral Anti-Diabetic Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Oral Anti-Diabetic Drug Sales Market Share by Manufacturers (2021-2026) Table 27. Global Oral Anti-Diabetic Drug Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 28. Global Oral Anti-Diabetic Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Oral Anti-Diabetic Drug Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Oral Anti-Diabetic Drug Manufacturers, Product Type & Application Table 31. Global Oral Anti-Diabetic Drug Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Oral Anti-Diabetic Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Oral Anti-Diabetic Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Oral Anti-Diabetic Drug Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Oral Anti-Diabetic Drug Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Oral Anti-Diabetic Drug Revenue Market Share by Type (2021-2026) Table 38. Global Oral Anti-Diabetic Drug Revenue Market Share by Type (2027-2032) Table 39. Global Oral Anti-Diabetic Drug Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 40. Global Oral Anti-Diabetic Drug Sales by Type (2021-2026) & (Tons) Table 41. Global Oral Anti-Diabetic Drug Sales by Type (2027-2032) & (Tons) Table 42. Global Oral Anti-Diabetic Drug Sales Market Share by Type (2021-2026) Table 43. Global Oral Anti-Diabetic Drug Sales Market Share by Type (2027-2032) Table 44. Global Oral Anti-Diabetic Drug Price by Type (2021-2026) & (US$/Ton) Table 45. Global Oral Anti-Diabetic Drug Price by Type (2027-2032) & (US$/Ton) Table 46. Global Oral Anti-Diabetic Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Oral Anti-Diabetic Drug Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Oral Anti-Diabetic Drug Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Oral Anti-Diabetic Drug Revenue Market Share by Application (2021-2026) Table 50. Global Oral Anti-Diabetic Drug Revenue Market Share by Application (2027-2032) Table 51. Global Oral Anti-Diabetic Drug Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 52. Global Oral Anti-Diabetic Drug Sales by Application (2021-2026) & (Tons) Table 53. Global Oral Anti-Diabetic Drug Sales by Application (2027-2032) & (Tons) Table 54. Global Oral Anti-Diabetic Drug Sales Market Share by Application (2021-2026) Table 55. Global Oral Anti-Diabetic Drug Sales Market Share by Application (2027-2032) Table 56. Global Oral Anti-Diabetic Drug Price by Application (2021-2026) & (US$/Ton) Table 57. Global Oral Anti-Diabetic Drug Price by Application (2027-2032) & (US$/Ton) Table 58. Astellas Company Information Table 59. Astellas Business Overview Table 60. Astellas Oral Anti-Diabetic Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 61. Astellas Oral Anti-Diabetic Drug Product Portfolio Table 62. Astellas Recent Development Table 63. Biocon Company Information Table 64. Biocon Business Overview Table 65. Biocon Oral Anti-Diabetic Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. Biocon Oral Anti-Diabetic Drug Product Portfolio Table 67. Biocon Recent Development Table 68. Boehringer Ingelheim Company Information Table 69. Boehringer Ingelheim Business Overview Table 70. Boehringer Ingelheim Oral Anti-Diabetic Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. Boehringer Ingelheim Oral Anti-Diabetic Drug Product Portfolio Table 72. Boehringer Ingelheim Recent Development Table 73. Bristol Myers Squibb Company Information Table 74. Bristol Myers Squibb Business Overview Table 75. Bristol Myers Squibb Oral Anti-Diabetic Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Bristol Myers Squibb Oral Anti-Diabetic Drug Product Portfolio Table 77. Bristol Myers Squibb Recent Development Table 78. Merck And Co. Company Information Table 79. Merck And Co. Business Overview Table 80. Merck And Co. Oral Anti-Diabetic Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Merck And Co. Oral Anti-Diabetic Drug Product Portfolio Table 82. Merck And Co. Recent Development Table 83. AstraZeneca Company Information Table 84. AstraZeneca Business Overview Table 85. AstraZeneca Oral Anti-Diabetic Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. AstraZeneca Oral Anti-Diabetic Drug Product Portfolio Table 87. AstraZeneca Recent Development Table 88. Pfizer Company Information Table 89. Pfizer Business Overview Table 90. Pfizer Oral Anti-Diabetic Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Pfizer Oral Anti-Diabetic Drug Product Portfolio Table 92. Pfizer Recent Development Table 93. Eli Lilly Company Information Table 94. Eli Lilly Business Overview Table 95. Eli Lilly Oral Anti-Diabetic Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Eli Lilly Oral Anti-Diabetic Drug Product Portfolio Table 97. Eli Lilly Recent Development Table 98. Novartis Company Information Table 99. Novartis Business Overview Table 100. Novartis Oral Anti-Diabetic Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Novartis Oral Anti-Diabetic Drug Product Portfolio Table 102. Novartis Recent Development Table 103. Sanofi Company Information Table 104. Sanofi Business Overview Table 105. Sanofi Oral Anti-Diabetic Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. Sanofi Oral Anti-Diabetic Drug Product Portfolio Table 107. Sanofi Recent Development Table 108. Takeda Company Information Table 109. Takeda Business Overview Table 110. Takeda Oral Anti-Diabetic Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. Takeda Oral Anti-Diabetic Drug Product Portfolio Table 112. Takeda Recent Development Table 113. Abbott Company Information Table 114. Abbott Business Overview Table 115. Abbott Oral Anti-Diabetic Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 116. Abbott Oral Anti-Diabetic Drug Product Portfolio Table 117. Abbott Recent Development Table 118. Janssen Pharmaceuticals Company Information Table 119. Janssen Pharmaceuticals Business Overview Table 120. Janssen Pharmaceuticals Oral Anti-Diabetic Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 121. Janssen Pharmaceuticals Oral Anti-Diabetic Drug Product Portfolio Table 122. Janssen Pharmaceuticals Recent Development Table 123. North America Oral Anti-Diabetic Drug Revenue by Type (2021-2026) & (US$ Million) Table 124. North America Oral Anti-Diabetic Drug Revenue by Type (2027-2032) & (US$ Million) Table 125. North America Oral Anti-Diabetic Drug Sales by Type (2021-2026) & (Tons) Table 126. North America Oral Anti-Diabetic Drug Sales by Type (2027-2032) & (Tons) Table 127. North America Oral Anti-Diabetic Drug Sales Price by Type (2021-2026) & (US$/Ton) Table 128. North America Oral Anti-Diabetic Drug Sales Price by Type (2027-2032) & (US$/Ton) Table 129. North America Oral Anti-Diabetic Drug Revenue by Application (2021-2026) & (US$ Million) Table 130. North America Oral Anti-Diabetic Drug Revenue by Application (2027-2032) & (US$ Million) Table 131. North America Oral Anti-Diabetic Drug Sales by Application (2021-2026) & (Tons) Table 132. North America Oral Anti-Diabetic Drug Sales by Application (2027-2032) & (Tons) Table 133. North America Oral Anti-Diabetic Drug Sales Price by Application (2021-2026) & (US$/Ton) Table 134. North America Oral Anti-Diabetic Drug Sales Price by Application (2027-2032) & (US$/Ton) Table 135. North America Oral Anti-Diabetic Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. North America Oral Anti-Diabetic Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 137. North America Oral Anti-Diabetic Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 138. North America Oral Anti-Diabetic Drug Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 139. North America Oral Anti-Diabetic Drug Sales by Country (2021-2026) & (Tons) Table 140. North America Oral Anti-Diabetic Drug Sales by Country (2027-2032) & (Tons) Table 141. North America Oral Anti-Diabetic Drug Sales Price by Country (2021-2026) & (US$/Ton) Table 142. North America Oral Anti-Diabetic Drug Sales Price by Country (2027-2032) & (US$/Ton) Table 143. United States Oral Anti-Diabetic Drug Revenue (2021-2032) & (US$ Million) Table 144. Canada Oral Anti-Diabetic Drug Revenue (2021-2032) & (US$ Million) Table 145. Europe Oral Anti-Diabetic Drug Revenue by Type (2021-2026) & (US$ Million) Table 146. Europe Oral Anti-Diabetic Drug Revenue by Type (2027-2032) & (US$ Million) Table 147. Europe Oral Anti-Diabetic Drug Sales by Type (2021-2026) & (Tons) Table 148. Europe Oral Anti-Diabetic Drug Sales by Type (2027-2032) & (Tons) Table 149. Europe Oral Anti-Diabetic Drug Sales Price by Type (2021-2026) & (US$/Ton) Table 150. Europe Oral Anti-Diabetic Drug Sales Price by Type (2027-2032) & (US$/Ton) Table 151. Europe Oral Anti-Diabetic Drug Revenue by Application (2021-2026) & (US$ Million) Table 152. Europe Oral Anti-Diabetic Drug Revenue by Application (2027-2032) & (US$ Million) Table 153. Europe Oral Anti-Diabetic Drug Sales by Application (2021-2026) & (Tons) Table 154. Europe Oral Anti-Diabetic Drug Sales by Application (2027-2032) & (Tons) Table 155. Europe Oral Anti-Diabetic Drug Sales Price by Application (2021-2026) & (US$/Ton) Table 156. Europe Oral Anti-Diabetic Drug Sales Price by Application (2027-2032) & (US$/Ton) Table 157. Europe Oral Anti-Diabetic Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. Europe Oral Anti-Diabetic Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 159. Europe Oral Anti-Diabetic Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 160. Europe Oral Anti-Diabetic Drug Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 161. Europe Oral Anti-Diabetic Drug Sales by Country (2021-2026) & (Tons) Table 162. Europe Oral Anti-Diabetic Drug Sales by Country (2027-2032) & (Tons) Table 163. Europe Oral Anti-Diabetic Drug Sales Price by Country (2021-2026) & (US$/Ton) Table 164. Europe Oral Anti-Diabetic Drug Sales Price by Country (2027-2032) & (US$/Ton) Table 165. Germany Oral Anti-Diabetic Drug Revenue (2021-2032) & (US$ Million) Table 166. France Oral Anti-Diabetic Drug Revenue (2021-2032) & (US$ Million) Table 167. U.K. Oral Anti-Diabetic Drug Revenue (2021-2032) & (US$ Million) Table 168. Italy Oral Anti-Diabetic Drug Revenue (2021-2032) & (US$ Million) Table 169. Netherlands Oral Anti-Diabetic Drug Revenue (2021-2032) & (US$ Million) Table 170. Nordic Countries Oral Anti-Diabetic Drug Revenue (2021-2032) & (US$ Million) Table 171. China Oral Anti-Diabetic Drug Revenue by Type (2021-2026) & (US$ Million) Table 172. China Oral Anti-Diabetic Drug Revenue by Type (2027-2032) & (US$ Million) Table 173. China Oral Anti-Diabetic Drug Sales by Type (2021-2026) & (Tons) Table 174. China Oral Anti-Diabetic Drug Sales by Type (2027-2032) & (Tons) Table 175. China Oral Anti-Diabetic Drug Sales Price by Type (2021-2026) & (US$/Ton) Table 176. China Oral Anti-Diabetic Drug Sales Price by Type (2027-2032) & (US$/Ton) Table 177. China Oral Anti-Diabetic Drug Revenue by Application (2021-2026) & (US$ Million) Table 178. China Oral Anti-Diabetic Drug Revenue by Application (2027-2032) & (US$ Million) Table 179. China Oral Anti-Diabetic Drug Sales by Application (2021-2026) & (Tons) Table 180. China Oral Anti-Diabetic Drug Sales by Application (2027-2032) & (Tons) Table 181. China Oral Anti-Diabetic Drug Sales Price by Application (2021-2026) & (US$/Ton) Table 182. China Oral Anti-Diabetic Drug Sales Price by Application (2027-2032) & (US$/Ton) Table 183. Asia Oral Anti-Diabetic Drug Revenue by Type (2021-2026) & (US$ Million) Table 184. Asia Oral Anti-Diabetic Drug Revenue by Type (2027-2032) & (US$ Million) Table 185. Asia Oral Anti-Diabetic Drug Sales by Type (2021-2026) & (Tons) Table 186. Asia Oral Anti-Diabetic Drug Sales by Type (2027-2032) & (Tons) Table 187. Asia Oral Anti-Diabetic Drug Sales Price by Type (2021-2026) & (US$/Ton) Table 188. Asia Oral Anti-Diabetic Drug Sales Price by Type (2027-2032) & (US$/Ton) Table 189. Asia Oral Anti-Diabetic Drug Revenue by Application (2021-2026) & (US$ Million) Table 190. Asia Oral Anti-Diabetic Drug Revenue by Application (2027-2032) & (US$ Million) Table 191. Asia Oral Anti-Diabetic Drug Sales by Application (2021-2026) & (Tons) Table 192. Asia Oral Anti-Diabetic Drug Sales by Application (2027-2032) & (Tons) Table 193. Asia Oral Anti-Diabetic Drug Sales Price by Application (2021-2026) & (US$/Ton) Table 194. Asia Oral Anti-Diabetic Drug Sales Price by Application (2027-2032) & (US$/Ton) Table 195. Asia Oral Anti-Diabetic Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. Asia Oral Anti-Diabetic Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. Asia Oral Anti-Diabetic Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. Asia Oral Anti-Diabetic Drug Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 199. Asia Oral Anti-Diabetic Drug Sales by Country (2021-2026) & (Tons) Table 200. Asia Oral Anti-Diabetic Drug Sales by Country (2027-2032) & (Tons) Table 201. Asia Oral Anti-Diabetic Drug Sales Price by Country (2021-2026) & (US$/Ton) Table 202. Asia Oral Anti-Diabetic Drug Sales Price by Country (2027-2032) & (US$/Ton) Table 203. Japan Oral Anti-Diabetic Drug Revenue (2021-2032) & (US$ Million) Table 204. South Korea Oral Anti-Diabetic Drug Revenue (2021-2032) & (US$ Million) Table 205. India Oral Anti-Diabetic Drug Revenue (2021-2032) & (US$ Million) Table 206. Australia Oral Anti-Diabetic Drug Revenue (2021-2032) & (US$ Million) Table 207. China Taiwan Oral Anti-Diabetic Drug Revenue (2021-2032) & (US$ Million) Table 208. Southeast Asia Oral Anti-Diabetic Drug Revenue (2021-2032) & (US$ Million) Table 209. SAMEA Oral Anti-Diabetic Drug Revenue by Type (2021-2026) & (US$ Million) Table 210. SAMEA Oral Anti-Diabetic Drug Revenue by Type (2027-2032) & (US$ Million) Table 211. SAMEA Oral Anti-Diabetic Drug Sales by Type (2021-2026) & (Tons) Table 212. SAMEA Oral Anti-Diabetic Drug Sales by Type (2027-2032) & (Tons) Table 213. SAMEA Oral Anti-Diabetic Drug Sales Price by Type (2021-2026) & (US$/Ton) Table 214. SAMEA Oral Anti-Diabetic Drug Sales Price by Type (2027-2032) & (US$/Ton) Table 215. SAMEA Oral Anti-Diabetic Drug Revenue by Application (2021-2026) & (US$ Million) Table 216. SAMEA Oral Anti-Diabetic Drug Revenue by Application (2027-2032) & (US$ Million) Table 217. SAMEA Oral Anti-Diabetic Drug Sales by Application (2021-2026) & (Tons) Table 218. SAMEA Oral Anti-Diabetic Drug Sales by Application (2027-2032) & (Tons) Table 219. SAMEA Oral Anti-Diabetic Drug Sales Price by Application (2021-2026) & (US$/Ton) Table 220. SAMEA Oral Anti-Diabetic Drug Sales Price by Application (2027-2032) & (US$/Ton) Table 221. SAMEA Oral Anti-Diabetic Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 222. SAMEA Oral Anti-Diabetic Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 223. SAMEA Oral Anti-Diabetic Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 224. SAMEA Oral Anti-Diabetic Drug Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 225. SAMEA Oral Anti-Diabetic Drug Sales by Country (2021-2026) & (Tons) Table 226. SAMEA Oral Anti-Diabetic Drug Sales by Country (2027-2032) & (Tons) Table 227. SAMEA Oral Anti-Diabetic Drug Sales Price by Country (2021-2026) & (US$/Ton) Table 228. SAMEA Oral Anti-Diabetic Drug Sales Price by Country (2027-2032) & (US$/Ton) Table 229. Brazil Oral Anti-Diabetic Drug Revenue (2021-2032) & (US$ Million) Table 230. Argentina Oral Anti-Diabetic Drug Revenue (2021-2032) & (US$ Million) Table 231. Chile Oral Anti-Diabetic Drug Revenue (2021-2032) & (US$ Million) Table 232. Colombia Oral Anti-Diabetic Drug Revenue (2021-2032) & (US$ Million) Table 233. Peru Oral Anti-Diabetic Drug Revenue (2021-2032) & (US$ Million) Table 234. Saudi Arabia Oral Anti-Diabetic Drug Revenue (2021-2032) & (US$ Million) Table 235. Israel Oral Anti-Diabetic Drug Revenue (2021-2032) & (US$ Million) Table 236. UAE Oral Anti-Diabetic Drug Revenue (2021-2032) & (US$ Million) Table 237. Turkey Oral Anti-Diabetic Drug Revenue (2021-2032) & (US$ Million) Table 238. Iran Oral Anti-Diabetic Drug Revenue (2021-2032) & (US$ Million) Table 239. Egypt Oral Anti-Diabetic Drug Revenue (2021-2032) & (US$ Million) Table 240. Key Raw Materials Table 241. Raw Materials Key Suppliers Table 242. Oral Anti-Diabetic Drug Distributors List Table 243. Oral Anti-Diabetic Drug Customers List Table 244. Research Programs/Design for This Report Table 245. Authors List of This Report Table 246. Secondary Sources Table 247. Primary Sources List of Figures Figure 1. Oral Anti-Diabetic Drug Image Figure 2. Global Oral Anti-Diabetic Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Anti-Diabetic Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Gliclazide Image Figure 5. Glimepiride Image Figure 6. Glyburide Image Figure 7. Others Image Figure 8. Global Oral Anti-Diabetic Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Oral Anti-Diabetic Drug Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Research Institual Image Figure 12. Global Oral Anti-Diabetic Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Oral Anti-Diabetic Drug Revenue (2021-2032) & (US$ Million) Figure 14. Global Oral Anti-Diabetic Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Oral Anti-Diabetic Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Oral Anti-Diabetic Drug Revenue Market Share by Region (2021-2032) Figure 17. Global Oral Anti-Diabetic Drug Sales (2021-2032) & (Tons) Figure 18. Global Oral Anti-Diabetic Drug Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 19. Global Oral Anti-Diabetic Drug Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Oral Anti-Diabetic Drug Sales YoY (2021-2032) & (Tons) Figure 21. Europe Oral Anti-Diabetic Drug Sales YoY (2021-2032) & (Tons) Figure 22. China Oral Anti-Diabetic Drug Sales YoY (2021-2032) & (Tons) Figure 23. Asia (Excluding China) Oral Anti-Diabetic Drug Sales YoY (2021-2032) & (Tons) Figure 24. South America, Middle East and Africa Oral Anti-Diabetic Drug Sales YoY (2021-2032) & (Tons) Figure 25. Global Oral Anti-Diabetic Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Oral Anti-Diabetic Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Oral Anti-Diabetic Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Oral Anti-Diabetic Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Oral Anti-Diabetic Drug Revenue Market Share by Type (2021-2032) Figure 31. Global Oral Anti-Diabetic Drug Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 32. Global Oral Anti-Diabetic Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Oral Anti-Diabetic Drug Sales Market Share by Type (2021-2032) Figure 34. Global Oral Anti-Diabetic Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Oral Anti-Diabetic Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Oral Anti-Diabetic Drug Revenue Market Share by Application (2021-2032) Figure 37. Global Oral Anti-Diabetic Drug Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 38. Global Oral Anti-Diabetic Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Oral Anti-Diabetic Drug Sales Market Share by Application (2021-2032) Figure 40. North America Oral Anti-Diabetic Drug Revenue Share by Type (2021-2032) Figure 41. North America Oral Anti-Diabetic Drug Sales Share by Type (2021-2032) Figure 42. North America Oral Anti-Diabetic Drug Revenue Share by Application (2021-2032) Figure 43. North America Oral Anti-Diabetic Drug Sales Share by Application (2021-2032) Figure 44. North America Oral Anti-Diabetic Drug Revenue Share by Country (2021-2032) Figure 45. North America Oral Anti-Diabetic Drug Sales Share by Country (2021-2032) Figure 46. Europe Oral Anti-Diabetic Drug Revenue Share by Type (2021-2032) Figure 47. Europe Oral Anti-Diabetic Drug Sales Share by Type (2021-2032) Figure 48. Europe Oral Anti-Diabetic Drug Revenue Share by Application (2021-2032) Figure 49. Europe Oral Anti-Diabetic Drug Sales Share by Application (2021-2032) Figure 50. Europe Oral Anti-Diabetic Drug Revenue Share by Country (2021-2032) Figure 51. Europe Oral Anti-Diabetic Drug Sales Share by Country (2021-2032) Figure 52. China Oral Anti-Diabetic Drug Revenue Share by Type (2021-2032) Figure 53. China Oral Anti-Diabetic Drug Sales Share by Type (2021-2032) Figure 54. China Oral Anti-Diabetic Drug Revenue Share by Application (2021-2032) Figure 55. China Oral Anti-Diabetic Drug Sales Share by Application (2021-2032) Figure 56. Asia Oral Anti-Diabetic Drug Revenue Share by Type (2021-2032) Figure 57. Asia Oral Anti-Diabetic Drug Sales Share by Type (2021-2032) Figure 58. Asia Oral Anti-Diabetic Drug Revenue Share by Application (2021-2032) Figure 59. Asia Oral Anti-Diabetic Drug Sales Share by Application (2021-2032) Figure 60. Asia Oral Anti-Diabetic Drug Revenue Share by Country (2021-2032) Figure 61. Asia Oral Anti-Diabetic Drug Sales Share by Country (2021-2032) Figure 62. SAMEA Oral Anti-Diabetic Drug Revenue Share by Type (2021-2032) Figure 63. SAMEA Oral Anti-Diabetic Drug Sales Share by Type (2021-2032) Figure 64. SAMEA Oral Anti-Diabetic Drug Revenue Share by Application (2021-2032) Figure 65. SAMEA Oral Anti-Diabetic Drug Sales Share by Application (2021-2032) Figure 66. SAMEA Oral Anti-Diabetic Drug Revenue Share by Country (2021-2032) Figure 67. SAMEA Oral Anti-Diabetic Drug Sales Share by Country (2021-2032) Figure 68. Oral Anti-Diabetic Drug Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Oral Anti-Diabetic Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Gliclazide
  • Glimepiride
  • Glyburide
  • Others
Applications
  • Hospital
  • Research Institual
Companies covered
  • Astellas
  • Biocon
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • Merck And Co.
  • AstraZeneca
  • Pfizer
  • Eli Lilly
  • Novartis
  • Sanofi
  • Takeda
  • Abbott
  • Janssen Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Oral Anti-Diabetic Drug Market by Type
  3. 1.2.1 Global Oral Anti-Diabetic Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Gliclazide
  5. 1.2.3 Glimepiride
  6. 1.2.4 Glyburide
  7. 1.2.5 Others
  8. 1.3 Oral Anti-Diabetic Drug Market by Application
  9. 1.3.1 Global Oral Anti-Diabetic Drug Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Research Institual
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Oral Anti-Diabetic Drug Market Dynamics
  1. 2.1 Oral Anti-Diabetic Drug Industry Trends
  2. 2.2 Oral Anti-Diabetic Drug Industry Drivers
  3. 2.3 Oral Anti-Diabetic Drug Industry Opportunities and Challenges
  4. 2.4 Oral Anti-Diabetic Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Oral Anti-Diabetic Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Oral Anti-Diabetic Drug Revenue by Region
  3. 3.2.1 Global Oral Anti-Diabetic Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Oral Anti-Diabetic Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Oral Anti-Diabetic Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Oral Anti-Diabetic Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Oral Anti-Diabetic Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Oral Anti-Diabetic Drug Sales by Region
  9. 3.4.1 Global Oral Anti-Diabetic Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Oral Anti-Diabetic Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Oral Anti-Diabetic Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Oral Anti-Diabetic Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Oral Anti-Diabetic Drug Revenue by Manufacturers
  2. 4.1.1 Global Oral Anti-Diabetic Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Oral Anti-Diabetic Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Oral Anti-Diabetic Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Oral Anti-Diabetic Drug Sales by Manufacturers
  6. 4.2.1 Global Oral Anti-Diabetic Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Oral Anti-Diabetic Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Oral Anti-Diabetic Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Oral Anti-Diabetic Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Oral Anti-Diabetic Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Oral Anti-Diabetic Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Oral Anti-Diabetic Drug Manufacturers, Product Type & Application
  13. 4.7 Global Oral Anti-Diabetic Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Oral Anti-Diabetic Drug Market CR5 and HHI
  16. 4.8.2 2025 Oral Anti-Diabetic Drug Tier 1, Tier 2, and Tier 3
5 Oral Anti-Diabetic Drug Market by Type
  1. 5.1 Global Oral Anti-Diabetic Drug Revenue by Type
  2. 5.1.1 Global Oral Anti-Diabetic Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Oral Anti-Diabetic Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Oral Anti-Diabetic Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Oral Anti-Diabetic Drug Sales by Type
  6. 5.2.1 Global Oral Anti-Diabetic Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Oral Anti-Diabetic Drug Sales by Type (2021-2032) & (Tons)
  8. 5.2.3 Global Oral Anti-Diabetic Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Oral Anti-Diabetic Drug Price by Type
6 Oral Anti-Diabetic Drug Market by Application
  1. 6.1 Global Oral Anti-Diabetic Drug Revenue by Application
  2. 6.1.1 Global Oral Anti-Diabetic Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Oral Anti-Diabetic Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Oral Anti-Diabetic Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Oral Anti-Diabetic Drug Sales by Application
  6. 6.2.1 Global Oral Anti-Diabetic Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Oral Anti-Diabetic Drug Sales by Application (2021-2032) & (Tons)
  8. 6.2.3 Global Oral Anti-Diabetic Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Oral Anti-Diabetic Drug Price by Application
7 Company Profiles
  1. 7.1 Astellas
  2. 7.1.1 Astellas Company Information
  3. 7.1.2 Astellas Business Overview
  4. 7.1.3 Astellas Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Astellas Oral Anti-Diabetic Drug Product Portfolio
  6. 7.1.5 Astellas Recent Developments
  7. 7.2 Biocon
  8. 7.2.1 Biocon Company Information
  9. 7.2.2 Biocon Business Overview
  10. 7.2.3 Biocon Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Biocon Oral Anti-Diabetic Drug Product Portfolio
  12. 7.2.5 Biocon Recent Developments
  13. 7.3 Boehringer Ingelheim
  14. 7.3.1 Boehringer Ingelheim Company Information
  15. 7.3.2 Boehringer Ingelheim Business Overview
  16. 7.3.3 Boehringer Ingelheim Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Boehringer Ingelheim Oral Anti-Diabetic Drug Product Portfolio
  18. 7.3.5 Boehringer Ingelheim Recent Developments
  19. 7.4 Bristol Myers Squibb
  20. 7.4.1 Bristol Myers Squibb Company Information
  21. 7.4.2 Bristol Myers Squibb Business Overview
  22. 7.4.3 Bristol Myers Squibb Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Bristol Myers Squibb Oral Anti-Diabetic Drug Product Portfolio
  24. 7.4.5 Bristol Myers Squibb Recent Developments
  25. 7.5 Merck And Co.
  26. 7.5.1 Merck And Co. Company Information
  27. 7.5.2 Merck And Co. Business Overview
  28. 7.5.3 Merck And Co. Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Merck And Co. Oral Anti-Diabetic Drug Product Portfolio
  30. 7.5.5 Merck And Co. Recent Developments
  31. 7.6 AstraZeneca
  32. 7.6.1 AstraZeneca Company Information
  33. 7.6.2 AstraZeneca Business Overview
  34. 7.6.3 AstraZeneca Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 AstraZeneca Oral Anti-Diabetic Drug Product Portfolio
  36. 7.6.5 AstraZeneca Recent Developments
  37. 7.7 Pfizer
  38. 7.7.1 Pfizer Company Information
  39. 7.7.2 Pfizer Business Overview
  40. 7.7.3 Pfizer Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Pfizer Oral Anti-Diabetic Drug Product Portfolio
  42. 7.7.5 Pfizer Recent Developments
  43. 7.8 Eli Lilly
  44. 7.8.1 Eli Lilly Company Information
  45. 7.8.2 Eli Lilly Business Overview
  46. 7.8.3 Eli Lilly Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Eli Lilly Oral Anti-Diabetic Drug Product Portfolio
  48. 7.8.5 Eli Lilly Recent Developments
  49. 7.9 Novartis
  50. 7.9.1 Novartis Company Information
  51. 7.9.2 Novartis Business Overview
  52. 7.9.3 Novartis Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Novartis Oral Anti-Diabetic Drug Product Portfolio
  54. 7.9.5 Novartis Recent Developments
  55. 7.10 Sanofi
  56. 7.10.1 Sanofi Company Information
  57. 7.10.2 Sanofi Business Overview
  58. 7.10.3 Sanofi Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Sanofi Oral Anti-Diabetic Drug Product Portfolio
  60. 7.10.5 Sanofi Recent Developments
  61. 7.11 Takeda
  62. 7.11.1 Takeda Company Information
  63. 7.11.2 Takeda Business Overview
  64. 7.11.3 Takeda Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Takeda Oral Anti-Diabetic Drug Product Portfolio
  66. 7.11.5 Takeda Recent Developments
  67. 7.12 Abbott
  68. 7.12.1 Abbott Company Information
  69. 7.12.2 Abbott Business Overview
  70. 7.12.3 Abbott Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Abbott Oral Anti-Diabetic Drug Product Portfolio
  72. 7.12.5 Abbott Recent Developments
  73. 7.13 Janssen Pharmaceuticals
  74. 7.13.1 Janssen Pharmaceuticals Company Information
  75. 7.13.2 Janssen Pharmaceuticals Business Overview
  76. 7.13.3 Janssen Pharmaceuticals Oral Anti-Diabetic Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Janssen Pharmaceuticals Oral Anti-Diabetic Drug Product Portfolio
  78. 7.13.5 Janssen Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Oral Anti-Diabetic Drug Market Size by Type
  2. 8.1.1 North America Oral Anti-Diabetic Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Oral Anti-Diabetic Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Oral Anti-Diabetic Drug Price by Type (2021-2032)
  5. 8.2 North America Oral Anti-Diabetic Drug Market Size by Application
  6. 8.2.1 North America Oral Anti-Diabetic Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Oral Anti-Diabetic Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Oral Anti-Diabetic Drug Price by Application (2021-2032)
  9. 8.3 North America Oral Anti-Diabetic Drug Market Size by Country
  10. 8.3.1 North America Oral Anti-Diabetic Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Oral Anti-Diabetic Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Oral Anti-Diabetic Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Oral Anti-Diabetic Drug Market Size by Type
  2. 9.1.1 Europe Oral Anti-Diabetic Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Oral Anti-Diabetic Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Oral Anti-Diabetic Drug Price by Type (2021-2032)
  5. 9.2 Europe Oral Anti-Diabetic Drug Market Size by Application
  6. 9.2.1 Europe Oral Anti-Diabetic Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Oral Anti-Diabetic Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Oral Anti-Diabetic Drug Price by Application (2021-2032)
  9. 9.3 Europe Oral Anti-Diabetic Drug Market Size by Country
  10. 9.3.1 Europe Oral Anti-Diabetic Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Oral Anti-Diabetic Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Oral Anti-Diabetic Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Oral Anti-Diabetic Drug Market Size by Type
  2. 10.1.1 China Oral Anti-Diabetic Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Oral Anti-Diabetic Drug Sales by Type (2021-2032)
  4. 10.1.3 China Oral Anti-Diabetic Drug Price by Type (2021-2032)
  5. 10.2 China Oral Anti-Diabetic Drug Market Size by Application
  6. 10.2.1 China Oral Anti-Diabetic Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Oral Anti-Diabetic Drug Sales by Application (2021-2032)
  8. 10.2.3 China Oral Anti-Diabetic Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Oral Anti-Diabetic Drug Market Size by Type
  2. 11.1.1 Asia Oral Anti-Diabetic Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Oral Anti-Diabetic Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Oral Anti-Diabetic Drug Price by Type (2021-2032)
  5. 11.2 Asia Oral Anti-Diabetic Drug Market Size by Application
  6. 11.2.1 Asia Oral Anti-Diabetic Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Oral Anti-Diabetic Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Oral Anti-Diabetic Drug Price by Application (2021-2032)
  9. 11.3 Asia Oral Anti-Diabetic Drug Market Size by Country
  10. 11.3.1 Asia Oral Anti-Diabetic Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Oral Anti-Diabetic Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Oral Anti-Diabetic Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Oral Anti-Diabetic Drug Market Size by Type
  2. 12.1.1 SAMEA Oral Anti-Diabetic Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Oral Anti-Diabetic Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Oral Anti-Diabetic Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Oral Anti-Diabetic Drug Market Size by Application
  6. 12.2.1 SAMEA Oral Anti-Diabetic Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Oral Anti-Diabetic Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Oral Anti-Diabetic Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Oral Anti-Diabetic Drug Market Size by Country
  10. 12.3.1 SAMEA Oral Anti-Diabetic Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Oral Anti-Diabetic Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Oral Anti-Diabetic Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Oral Anti-Diabetic Drug Value Chain Analysis
  2. 13.1.1 Oral Anti-Diabetic Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Oral Anti-Diabetic Drug Production Mode & Process
  6. 13.2 Oral Anti-Diabetic Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Oral Anti-Diabetic Drug Distributors
  9. 13.2.3 Oral Anti-Diabetic Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst